The Patented Medicine Prices Review Board (PMPRB) released the August 2018 issue of its NEWSletter which includes an update on the PMPRB’s Guideline Reform, including recent meetings held by the Steering Committee and the Technical Working Group.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.